Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
1.780
-0.050 (-2.73%)
At close: Oct 23, 2026
Can-Fite BioPharma Employees
Can-Fite BioPharma had 5 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
5
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$81,000
Profits / Employee
-$1,910,600
Market Cap
5.81M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 5 | 0 | - |
| Dec 31, 2024 | 5 | -3 | -37.50% |
| Dec 31, 2023 | 8 | 0 | - |
| Dec 31, 2022 | 8 | 0 | - |
| Sep 30, 2022 | 8 | 0 | - |
| Dec 31, 2021 | 8 | 0 | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| Senti Biosciences Holdings | 39 |
| Moleculin Biotech | 17 |
| Processa Pharmaceuticals | 12 |
| Traws Pharma | 7 |
| Alzamend Neuro | 6 |
| Enveric Biosciences | 6 |
| XTL Biopharmaceuticals | 5 |
CANF News
- 4 weeks ago - Can-Fite BioPharma Registration statement: Registration filing - Filings
- 4 weeks ago - Can-Fite BioPharma Registration statement: Registration filing - Filings
- 6 weeks ago - Can-Fite: Publication Reports Improvement in Decompensated Cirrhosis with Namodenoson and Successful Bridging to Liver Transplantation - GlobeNewsWire
- 6 weeks ago - Can-Fite Reports Q2 2026 Financial Results and Ongoing Clinical Progress Highlighting Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study - GlobeNewsWire
- 6 weeks ago - Can-Fite BioPharma Earnings release: Q2 2026 - Filings
- 7 weeks ago - Can-Fite Enters Warrant Exercise Deal For $4 Mln, Shares To Be Issued At Discount; Stock Plunges - Nasdaq
- 7 weeks ago - CANF Looks 45.6% Undervalued on GF Value™ Despite Challenging Fundamentals - GuruFocus
- 7 weeks ago - Can-Fite Announces Exercise of Warrants for Approximately $4.0 Million in Gross Proceeds - GlobeNewsWire